| Distribution | Full List | Categories |
| by Country | by Vaccine |
| PEOPLE VACCINATED | LAST 7 DAYS | |||||
| countries over 1M population |
1st dose |
last dose |
1st dose |
last dose |
any dose |
|
| United Arab Emirates |
101.0% 9,991,089 |
99.0% 9,792,266 |
0.1% 6k |
|||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Portugal |
95.5% 9,740,081 |
87.3% 8,899,233 |
0.0% | 0.0% |
0.3% 28k |
|
| Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Qatar |
95.5% 2,751,485 |
95.5% 2,751,485 |
0.1% | 0.1% |
0.5% 13k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Chile |
94.4% 18,042,374 |
92.3% 17,638,133 |
0.0% | 0.0% |
1.0% 200k |
|
| CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Cuba |
94.3% 10,686,904 |
88.1% 9,980,556 |
0.0% | 0.0% |
3.6% 408k |
|
| Abdala, Soberana Plus, Soberana02 | ||||||
| Argentina |
91.2% 41,220,305 |
83.4% 37,699,441 |
0.0% | 0.0% |
0.4% 187k |
|
| CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Nicaragua |
90.8% 6,018,721 |
85.2% 5,641,315 |
0.4% | 0.4% |
0.9% 58k |
|
| Abdala, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Soberana02, Sputnik Light, Sputnik V | ||||||
| China |
90.4% 1,301,392,000 |
88.1% 1,268,285,000 |
0.2% | 0.2% | ||
| CanSino, IMBCAMS, KCONVAC, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001 | ||||||
| Cambodia |
90.4% 15,115,433 |
86.3% 14,427,169 |
0.1% | 0.1% |
1.9% 314k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Hong Kong |
90.4% 6,775,049 |
87.1% 6,528,724 |
0.1% | 0.2% |
1.4% 101k |
|
| Pfizer/BioNTech, Sinovac | ||||||
| Vietnam |
90.1% 87,717,272 |
83.3% 81,040,637 |
0.5% | 0.4% |
3.4% 3,312k |
|
| Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Peru |
90.1% 29,706,745 |
84.8% 27,943,524 |
0.0% | 0.1% |
0.9% 305k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Taiwan |
89.7% 21,356,298 |
83.8% 19,963,176 |
0.1% | 0.1% |
0.9% 203k |
|
| Medigen, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| New Zealand |
89.1% 4,295,715 |
85.6% 4,128,619 |
0.0% | 0.0% |
1.2% 58k |
|
| Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Spain |
88.3% 41,281,380 |
86.9% 40,614,299 |
0.0% | 0.0% |
0.1% 58k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| South Korea |
88.0% 45,093,844 |
87.1% 44,657,345 |
0.0% | 0.0% |
1.0% 539k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Australia |
87.9% 22,406,608 |
85.3% 21,741,971 |
0.0% | 0.0% |
0.2% 48k |
|
| Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Costa Rica |
87.6% 4,460,393 |
82.2% 4,186,342 |
0.0% | 0.1% |
1.6% 81k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Brazil |
87.4% 185,892,530 |
80.4% 170,983,152 |
0.1% | 0.2% |
0.1% 300k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Canada |
86.9% 32,792,945 |
83.5% 31,504,328 |
0.0% | 0.0% |
0.6% 244k |
|
| Johnson&Johnson, Medicago, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Malaysia |
86.8% 28,080,188 |
84.9% 27,468,521 |
0.0% | 0.0% |
0.2% 55k |
|
| CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Nepal |
86.7% 25,251,001 |
70.8% 20,640,381 |
0.6% | 0.2% |
1.0% 305k |
|
| Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Uruguay |
86.3% 2,999,376 |
83.2% 2,890,618 |
0.0% | 0.0% |
0.1% 3k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Ecuador |
86.3% 15,219,781 |
79.7% 14,063,328 |
0.0% | 0.1% |
1.4% 240k |
|
| CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Singapore |
85.9% 5,022,906 |
85.5% 5,001,013 |
0.0% | 0.0% |
0.2% 10k |
|
| Moderna, Novavax, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Rwanda |
84.5% 10,940,142 |
81.0% 10,488,764 |
0.3% |
2.0% 266k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Italy |
84.1% 50,822,127 |
79.3% 47,958,389 |
0.0% | 0.0% |
0.4% 229k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Colombia |
83.7% 42,573,293 |
71.5% 36,397,439 |
0.1% | 0.1% |
0.6% 303k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| France |
83.5% 54,530,622 |
81.2% 53,011,310 |
0.0% | 0.0% |
0.4% 236k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Denmark |
83.3% 4,823,182 |
82.7% 4,787,582 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Ireland |
82.9% 4,093,545 |
82.0% 4,047,404 |
0.0% | 0.0% |
0.1% 2k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Japan |
82.2% 103,981,749 |
81.1% 102,557,779 |
0.0% | 0.0% |
2.8% 3,495k |
|
| Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Finland |
81.6% 4,520,167 |
78.3% 4,339,176 |
0.0% | 0.0% |
1.5% 84k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Thailand |
81.5% 56,878,496 |
76.3% 53,255,291 |
0.0% | 0.1% |
0.5% 338k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Panama |
81.0% 3,493,065 |
72.6% 3,133,918 |
0.1% | 0.1% |
0.8% 33k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Laos |
80.9% 5,885,061 |
71.8% 5,220,015 |
0.1% | 0.2% |
0.3% 25k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Kuwait |
80.6% 3,440,132 |
78.0% 3,330,480 |
0.0% | 0.0% |
0.2% 7k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Mauritius |
80.4% 1,021,934 |
76.9% 977,728 |
0.1% 2k |
|||
| Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Norway |
80.1% 4,343,588 |
74.7% 4,050,422 |
0.0% | 0.0% |
0.5% 27k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Sri Lanka |
79.9% 17,106,561 |
68.0% 14,558,718 |
0.0% | 0.0% |
0.2% 37k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Belgium |
79.8% 9,252,460 |
79.0% 9,155,596 |
0.0% | 0.0% |
0.1% 8k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| United Kingdom |
79.2% 53,731,979 |
74.5% 50,549,087 |
0.0% | 0.1% |
0.2% 163k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| United States |
79.0% 261,591,428 |
67.4% 223,035,566 |
0.1% | 0.1% |
0.3% 1,156k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Bangladesh |
79.0% 130,137,673 |
73.3% 120,703,120 |
0.1% | 0.1% |
0.8% 1,251k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Venezuela |
77.9% 22,157,232 |
50.2% 14,287,370 |
||||
| Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V | ||||||
| Sweden |
77.6% 7,838,695 |
75.8% 7,651,988 |
0.0% | 0.0% |
0.4% 43k |
|
| Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Israel |
77.6% 6,715,601 |
71.1% 6,150,254 |
0.0% | 0.0% |
0.0% 2k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Germany |
77.3% 64,739,711 |
75.7% 63,404,911 |
0.0% | 0.0% |
0.2% 173k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iran |
77.0% 64,698,435 |
69.1% 58,058,144 |
0.0% | 0.0% |
0.2% 163k |
|
| COVIran Barekat, Covaxin, FAKHRAVAC, Oxford/AstraZeneca, Razi Cov Pars, Sinopharm/Beijing, Soberana02, SpikoGen, Sputnik V | ||||||
| Saudi Arabia |
76.7% 26,713,922 |
72.1% 25,082,132 |
0.1% | 0.2% |
1.0% 359k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Austria |
76.4% 6,881,034 |
75.7% 6,819,895 |
0.0% |
0.4% 40k |
||
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Greece |
76.0% 7,924,230 |
73.2% 7,634,074 |
0.0% | 0.0% |
0.2% 24k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Netherlands |
75.6% 12,950,702 |
70.7% 12,111,092 |
0.0% | 0.0% |
0.5% 87k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Tunisia |
75.2% 8,893,118 |
54.0% 6,379,291 |
0.0% | 0.0% |
0.1% 8k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Indonesia |
74.2% 202,813,315 |
62.3% 170,356,449 |
0.1% | 0.1% |
0.6% 1,759k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| India |
74.1% 1,022,620,253 |
67.9% 936,496,147 |
0.1% | 0.2% |
1.5% 21,196k |
|
| Corbevax, Covaxin, Novavax, Oxford/AstraZeneca, Sputnik V | ||||||
| Mexico |
72.9% 94,045,513 |
62.0% 79,947,470 |
0.7% | |||
| CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Bahrain |
72.8% 1,239,636 |
72.0% 1,224,632 |
0.0% | 0.0% |
0.1% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Botswana |
72.1% 1,696,430 |
64.3% 1,512,567 |
0.1% 3k |
|||
| Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Lithuania |
71.8% 1,953,800 |
69.0% 1,877,502 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| El Salvador |
71.4% 4,630,037 |
66.8% 4,330,643 |
0.1% | 0.1% |
0.8% 50k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Latvia |
71.4% 1,346,184 |
69.2% 1,305,976 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Switzerland |
70.4% 6,092,117 |
69.4% 6,007,428 |
0.0% | 0.0% |
0.2% 22k |
|
| Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech | ||||||
| Philippines |
70.1% 76,848,338 |
65.9% 72,226,419 |
0.2% | 0.2% |
0.7% 802k |
|
| Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Mongolia |
69.3% 2,272,965 |
66.4% 2,175,617 |
0.0% 1k |
|||
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Turkey |
68.7% 57,898,165 |
63.0% 53,128,263 |
0.0% | 0.0% |
0.6% 485k |
|
| Pfizer/BioNTech, Sinovac, Turkovac | ||||||
| Belarus |
68.1% 6,437,839 |
67.0% 6,332,753 |
0.0% | 0.0% |
0.7% 63k |
|
| KoviVac/Chumakov, Sinopharm/Beijing, Sputnik Light, Sputnik V | ||||||
| Morocco |
67.7% 24,978,724 |
63.6% 23,469,735 |
0.0% | 0.0% |
0.1% 22k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Dominican Republic |
66.9% 7,260,034 |
55.5% 6,021,536 |
0.0% | 0.0% |
0.2% 20k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Hungary |
66.3% 6,407,918 |
64.1% 6,194,102 |
0.0% | 0.0% |
0.1% 7k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Estonia |
65.2% 864,875 |
63.6% 844,120 |
0.0% | 0.0% |
0.4% 5k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Czechia |
65.1% 6,970,225 |
64.3% 6,884,444 |
0.0% | 0.0% |
0.3% 31k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Timor |
64.2% 846,537 |
55.8% 735,782 |
0.1% | 0.2% |
0.7% 9k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Oman |
64.1% 3,270,883 |
59.6% 3,044,224 |
0.0% | 0.0% |
0.1% 3k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Myanmar |
63.9% 34,777,314 |
50.6% 27,545,329 |
2.3% | 0.7% |
6.0% 3,287k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Honduras |
63.2% 6,261,004 |
55.5% 5,493,660 |
0.3% | 0.4% |
1.1% 106k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Pakistan |
62.7% 138,563,296 |
58.9% 130,069,746 |
0.1% | 0.2% |
0.7% 1,625k |
|
| CanSino, Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Bolivia |
62.5% 7,299,112 |
52.1% 6,080,564 |
0.1% | 0.1% |
0.8% 92k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Slovenia |
60.9% 1,265,802 |
58.8% 1,222,225 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Poland |
60.1% 22,755,383 |
59.5% 22,532,606 |
0.0% | 0.0% |
1.0% 367k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Uzbekistan |
59.4% 19,890,447 |
47.2% 15,794,134 |
0.3% | 0.3% |
3.6% 1,204k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001 | ||||||
| Russia |
56.6% 82,629,761 |
51.6% 75,250,305 |
0.1% | 0.1% |
0.4% 576k |
|
| EpiVacCorona, Sputnik V | ||||||
| Croatia |
56.4% 2,316,695 |
54.7% 2,246,721 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Paraguay |
55.4% 3,948,425 |
49.0% 3,491,828 |
0.0% | 0.1% |
0.4% 29k |
|
| Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Tajikistan |
54.7% 5,220,731 |
52.8% 5,034,819 |
0.1% | 0.1% |
2.7% 256k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Trinidad and Tobago |
53.8% 752,491 |
51.2% 715,788 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Azerbaijan |
53.0% 5,369,091 |
47.9% 4,859,079 |
0.0% | 0.0% |
0.1% 10k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Liberia |
52.3% 2,645,947 |
46.0% 2,328,125 |
3.7% | 3.9% |
4.1% 205k |
|
| Oxford/AstraZeneca | ||||||
| Slovakia |
51.7% 2,822,919 |
50.6% 2,763,688 |
0.0% |
0.0% 0k |
||
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Egypt |
50.9% 52,066,692 |
38.0% 38,866,849 |
0.2% | 0.2% |
0.6% 597k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Kazakhstan |
50.0% 9,394,344 |
48.0% 9,010,266 |
0.1% | 0.3% |
0.4% 75k |
|
| QazVac, Sinopharm/Beijing, Sputnik V | ||||||
| Serbia |
49.3% 3,354,075 |
48.2% 3,278,198 |
0.0% | 0.0% |
0.0% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Mozambique |
47.9% 14,978,771 |
45.1% 14,098,645 |
||||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Guatemala |
47.5% 8,501,331 |
37.0% 6,628,196 |
0.6% | 0.9% |
2.1% 384k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Jordan |
47.2% 4,816,724 |
44.6% 4,554,791 |
0.0% | 0.0% |
0.0% 3k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Kosovo |
46.9% 905,778 |
42.7% 824,292 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Albania |
46.2% 1,330,520 |
43.6% 1,253,962 |
0.0% | 0.0% |
0.2% 7k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Lesotho |
43.1% 924,248 |
40.7% 872,661 |
0.4% | 0.2% |
0.3% 5k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Zimbabwe |
42.9% 6,376,117 |
31.6% 4,692,440 |
0.1% | 0.1% |
0.2% 35k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Mauritania |
42.8% 1,992,317 |
30.3% 1,410,195 |
1.4% | 1.6% |
4.3% 199k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Angola |
42.3% 13,908,654 |
23.2% 7,638,251 |
0.4% | 0.2% |
0.5% 150k |
|
| Oxford/AstraZeneca | ||||||
| Georgia |
41.1% 1,639,970 |
31.9% 1,273,576 |
0.1% | 0.0% |
0.1% 3k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| North Macedonia |
41.0% 854,061 |
40.2% 837,577 |
0.0% | 0.0% |
0.1% 2k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik V | ||||||
| Uganda |
39.8% 18,203,390 |
27.2% 12,434,786 |
0.1% | 0.2% |
0.2% 102k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Lebanon |
39.7% 2,712,342 |
35.0% 2,387,834 |
0.0% | 0.0% |
0.1% 5k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Cote d'Ivoire |
39.7% 10,469,471 |
31.7% 8,369,532 |
0.9% | 1.2% |
2.2% 593k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Palestine |
39.4% 2,009,619 |
34.8% 1,773,409 |
0.0% | 0.0% |
0.0% 1k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Ethiopia |
38.9% 44,695,420 |
33.3% 38,296,046 |
0.1% 142k |
|||
| Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac | ||||||
| Armenia |
38.1% 1,129,669 |
33.3% 985,807 |
0.0% | 0.0% |
0.0% 1k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik Light, Sputnik V | ||||||
| South Africa |
37.4% 22,186,697 |
32.5% 19,244,003 |
0.0% | 0.0% |
0.1% 52k |
|
| Johnson&Johnson, Pfizer/BioNTech | ||||||
| Ukraine |
36.1% 15,774,300 |
34.7% 15,153,577 |
0.2% | 0.0% |
0.4% 171k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Ghana |
35.5% 11,042,809 |
25.4% 7,880,395 |
0.6% | 0.6% | ||
| Oxford/AstraZeneca, Sputnik V | ||||||
| Guinea |
35.3% 4,640,906 |
20.6% 2,712,094 |
0.3% 45k |
|||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Libya |
33.4% 2,295,434 |
17.8% 1,219,637 |
0.1% | 0.0% |
0.1% 6k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Sierra Leone |
33.2% 2,645,861 |
24.0% 1,918,592 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Bosnia and Herzegovina |
28.8% 943,394 |
25.8% 846,080 |
0.3% | 0.3% |
0.9% 30k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Romania |
28.5% 5,474,507 |
42.2% 8,114,769 |
0.0% |
0.0% 8k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Jamaica |
27.8% 823,291 |
24.4% 721,425 |
0.1% | 0.1% |
0.1% 3k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| WORLD |
27.5% 2,147,483,647 |
27.5% 2,147,483,647 |
||||
| Bulgaria |
27.4% 1,904,143 |
29.7% 2,066,347 |
0.0% |
0.2% 14k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iraq |
27.4% 11,014,427 |
19.2% 7,741,261 |
0.1% | 0.0% |
0.1% 34k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Tanzania |
27.3% 16,315,065 |
24.7% 14,775,183 |
2.4% | 2.3% |
2.6% 1,528k |
|
| Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Central African Republic |
27.0% 1,301,882 |
25.8% 1,245,498 |
0.0% | 0.0% | ||
| Covaxin, Oxford/AstraZeneca | ||||||
| Guinea-Bissau |
26.9% 529,954 |
17.4% 342,389 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Benin |
26.3% 3,190,518 |
22.2% 2,690,085 |
0.0% | |||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Togo |
25.5% 2,115,629 |
18.8% 1,557,538 |
0.1% | |||
| Oxford/AstraZeneca | ||||||
| Kyrgyzstan |
24.2% 1,576,343 |
20.3% 1,324,818 |
0.0% | 0.0% |
0.0% 2k |
|
| Sinopharm/Beijing, Sputnik V | ||||||
| Moldova |
23.5% 948,882 |
26.4% 1,063,425 |
0.0% |
0.1% 4k |
||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Kenya |
23.5% 12,641,679 |
17.4% 9,326,814 |
0.1% | 0.1% |
0.2% 84k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Afghanistan |
23.3% 9,066,437 |
21.2% 8,272,846 |
2.9% | 2.8% |
2.9% 1,134k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Namibia |
21.9% 556,375 |
19.0% 482,539 |
0.8% | 0.8% |
0.9% 24k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Equatorial Guinea |
19.2% 270,109 |
15.3% 214,032 |
0.0% | 0.1% |
0.1% 1k |
|
| Sinopharm/Beijing, Sinovac | ||||||
| Algeria |
18.7% 8,210,605 |
15.6% 6,851,660 |
0.2% | 0.2% | ||
| Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Gambia |
18.7% 452,514 |
14.8% 357,390 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Nigeria |
17.7% 36,549,506 |
12.0% 24,675,659 |
0.1% | 0.2% |
0.3% 658k |
|
| Oxford/AstraZeneca | ||||||
| Somalia |
17.7% 2,807,072 |
12.8% 2,040,506 |
0.4% | 1.5% |
1.7% 266k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Syria |
16.2% 2,842,478 |
10.9% 1,914,784 |
0.4% | 0.3% |
0.6% 104k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Niger |
15.5% 3,750,520 |
12.3% 2,986,249 |
0.2% | 0.2% |
0.3% 69k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Sudan |
15.2% 6,651,268 |
10.4% 4,536,964 |
1.5% | 1.8% |
1.9% 851k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Gabon |
13.9% 309,473 |
11.5% 256,802 |
0.0% | 0.0% |
0.0% 1k |
|
| Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Senegal |
13.7% 2,300,648 |
6.3% 1,051,041 |
2.5% | |||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Zambia |
13.5% 2,487,149 |
28.1% 5,158,680 |
1.3% |
1.9% 340k |
||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| South Sudan |
13.5% 1,513,206 |
13.1% 1,471,227 |
0.5% | 0.5% |
0.5% 51k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Chad |
13.5% 2,218,493 |
12.8% 2,093,522 |
0.0% | 0.0% |
0.0% 1k |
|
| Sinopharm/Beijing | ||||||
| Malawi |
12.9% 2,469,812 |
10.1% 1,932,524 |
0.4% | 0.5% |
0.8% 160k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Congo |
12.6% 695,760 |
11.9% 654,119 |
0.0% | 0.0% |
0.0% 0k |
|
| Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V | ||||||
| Burkina Faso |
12.2% 2,551,596 |
7.8% 1,640,349 |
0.2% | 0.1% |
0.3% 62k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Mali |
10.2% 2,060,837 |
7.4% 1,498,260 |
0.2% | 0.1% |
0.2% 49k |
|
| Oxford/AstraZeneca | ||||||
| Cameroon |
5.9% 1,569,870 |
4.6% 1,226,658 |
0.0% | 0.0% |
0.0% 2k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Madagascar |
5.0% 1,393,303 |
4.8% 1,341,878 |
0.1% | 0.1% |
0.1% 28k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Eswatini |
4.7% 410,506 |
4.0% 342,088 |
0.4% 31k |
|||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Democratic Republic of Congo |
4.2% 3,806,618 |
2.8% 2,471,211 |
0.1% | 0.1% |
0.1% 125k |
|
| Oxford/AstraZeneca | ||||||
| Papua New Guinea |
3.8% 341,307 |
3.2% 281,948 |
0.1% 11k |
|||
| Oxford/AstraZeneca | ||||||
| Yemen |
2.4% 712,781 |
1.5% 452,843 |
0.0% | 0.0% |
0.0% 1k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Haiti |
2.2% 249,913 |
1.4% 162,599 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna | ||||||
| Burundi |
0.2% 17,474 |
0.1% 16,882 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Sinopharm/Beijing | ||||||
| PEOPLE VACCINATED | LAST 7 DAYS | |||||
| countries below 1M population |
1st dose |
last dose |
1st dose |
last dose |
any dose |
|
| Gibraltar |
124.9% 42,074 |
122.9% 41,421 |
0.1% |
0.8% 0k |
||
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Samoa |
115.6% 229,291 |
100.2% 198,896 |
0.9% 2k |
|||
| Oxford/AstraZeneca | ||||||
| Malta |
108.2% 477,508 |
106.5% 470,395 |
0.0% | 0.0% |
0.4% 2k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Tonga |
102.4% 108,263 |
91.9% 97,151 |
1.0% 1k |
|||
| Oxford/AstraZeneca | ||||||
| Niue |
102.0% 1,650 |
87.6% 1,417 |
1.2% |
6.1% 0k |
||
| Pfizer/BioNTech | ||||||
| Brunei |
101.9% 445,849 |
99.7% 436,027 |
0.2% | 1.1% |
2.0% 9k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Pitcairn |
100.0% 47 |
100.0% 47 |
||||
| Oxford/AstraZeneca | ||||||
| Nauru |
96.8% 10,493 |
79.2% 8,585 |
3.2% |
3.2% 0k |
||
| Oxford/AstraZeneca | ||||||
| Macao |
95.3% 618,852 |
90.8% 589,575 |
0.3% | 0.0% |
1.6% 11k |
|
| Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Cayman Islands |
93.7% 61,583 |
91.3% 60,034 |
0.1% | 0.1% |
0.4% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iceland |
90.8% 309,770 |
85.0% 290,193 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bhutan |
90.0% 694,208 |
87.3% 673,485 |
0.1% | 0.1% |
0.4% 3k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Seychelles |
86.7% 85,268 |
82.4% 81,049 |
0.0% | 0.0% |
0.8% 1k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V | ||||||
| Cook Islands |
85.6% 15,033 |
83.6% 14,685 |
0.1% 0k |
|||
| Pfizer/BioNTech | ||||||
| Faeroe Islands |
85.4% 41,715 |
83.7% 40,895 |
0.0% | 0.0% |
0.3% 0k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Aruba |
83.9% 89,574 |
78.0% 83,293 |
0.1% | 0.0% |
0.1% 0k |
|
| Pfizer/BioNTech | ||||||
| Turks and Caicos Islands |
83.1% 32,189 |
77.8% 30,129 |
0.1% | 0.1% |
0.2% 0k |
|
| Pfizer/BioNTech | ||||||
| Jersey |
82.9% 83,844 |
80.3% 81,163 |
0.0% | 0.1% |
0.3% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Isle of Man |
81.8% 69,560 |
78.9% 67,106 |
0.0% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Guernsey |
80.8% 54,146 |
76.6% 51,351 |
0.4% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Fiji |
79.0% 708,265 |
71.0% 636,744 |
0.0% | 0.0% |
0.4% 4k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bermuda |
78.0% 48,554 |
76.5% 47,657 |
0.1% 0k |
|||
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| San Marino |
77.7% 26,357 |
69.6% 23,633 |
0.1% 0k |
|||
| Pfizer/BioNTech, Sputnik V | ||||||
| Luxembourg |
76.9% 481,549 |
6.1% 37,870 |
0.0% |
0.8% 5k |
||
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Cyprus |
76.4% 668,933 |
73.7% 645,367 |
0.0% | 0.0% |
0.1% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Falkland Islands |
75.6% 2,632 |
51.0% 1,775 |
0.8% | 1.7% |
2.4% 0k |
|
| Oxford/AstraZeneca | ||||||
| Andorra |
74.9% 57,888 |
69.2% 53,460 |
0.1% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Maldives |
73.8% 399,025 |
71.2% 384,787 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Monaco |
73.6% 28,875 |
65.4% 25,667 |
0.4% | 0.4% |
2.8% 1k |
|
| Pfizer/BioNTech | ||||||
| Bonaire Sint Eustatius and Saba |
72.9% 19,109 |
63.8% 16,736 |
2.5% | 2.8% |
5.2% 1k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Greenland |
72.7% 41,243 |
67.8% 38,502 |
0.0% 0k |
|||
| Moderna | ||||||
| Anguilla |
72.2% 10,837 |
68.5% 10,273 |
0.1% | 0.3% |
0.4% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Liechtenstein |
70.2% 26,754 |
69.3% 26,439 |
0.1% 0k |
|||
| Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech | ||||||
| Kiribati |
68.3% 81,548 |
51.9% 61,975 |
0.1% | 0.1% |
0.7% 1k |
|
| Oxford/AstraZeneca | ||||||
| French Polynesia |
67.1% 188,352 |
65.7% 184,491 |
0.1% |
0.1% 0k |
||
| Johnson&Johnson, Pfizer/BioNTech | ||||||
| Sint Maarten (Dutch part) |
66.5% 28,502 |
61.8% 26,515 |
0.1% | 0.1% |
0.2% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| New Caledonia |
66.1% 188,554 |
63.2% 180,518 |
0.0% | 0.0% |
0.1% 0k |
|
| Pfizer/BioNTech | ||||||
| Curacao |
66.1% 108,386 |
60.8% 99,746 |
0.0% | 0.0% |
0.1% 0k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Antigua and Barbuda |
65.4% 64,091 |
63.3% 62,031 |
0.0% | 0.1% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| British Virgin Islands |
64.3% 19,433 |
60.2% 18,187 |
0.1% | 0.1% |
0.2% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Cape Verde |
64.0% 355,957 |
55.4% 308,044 |
0.0% | 0.0% |
1.4% 8k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Saint Kitts and Nevis |
63.5% 33,794 |
50.7% 26,944 |
3.1% | 0.2% |
3.3% 2k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Belize |
62.8% 249,641 |
55.0% 218,586 |
0.0% | 0.1% |
0.1% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Guyana |
61.8% 485,891 |
58.7% 461,605 |
0.1% | 0.0% |
0.1% 1k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Wallis and Futuna |
57.7% 6,483 |
57.4% 6,457 |
0.4% 0k |
|||
| Moderna | ||||||
| Sao Tome and Principe |
57.6% 126,163 |
45.9% 100,631 |
0.1% | 0.3% |
0.4% 1k |
|
| Oxford/AstraZeneca | ||||||
| Barbados |
56.7% 163,015 |
53.6% 154,127 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Vanuatu |
56.1% 172,232 |
42.5% 130,607 |
0.9% 3k |
|||
| Oxford/AstraZeneca | ||||||
| Comoros |
48.7% 423,255 |
43.9% 382,032 |
0.3% | 0.0% | ||
| Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Montenegro |
46.5% 292,393 |
45.3% 284,478 |
0.0% | 0.0% |
0.1% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Dominica |
45.7% 32,872 |
42.5% 30,566 |
0.0% |
0.1% 0k |
||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Suriname |
45.7% 267,820 |
40.5% 237,879 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Bahamas |
43.6% 171,391 |
41.4% 162,729 |
1.2% | 0.4% |
1.7% 7k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Solomon Islands |
43.0% 295,016 |
28.0% 192,043 |
0.3% | 0.2% |
1.3% 9k |
|
| Oxford/AstraZeneca | ||||||
| Montserrat |
41.5% 2,076 |
38.5% 1,923 |
0.2% 0k |
|||
| Oxford/AstraZeneca | ||||||
| Grenada |
39.0% 43,913 |
34.4% 38,702 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Saint Vincent and the Grenadines |
33.4% 37,038 |
28.1% 31,167 |
0.0% | 0.0% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik Light, Sputnik V | ||||||
| Saint Lucia |
32.6% 59,852 |
29.8% 54,643 |
0.0% | 0.1% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Djibouti |
21.4% 211,044 |
19.3% 190,673 |
0.4% | 0.4% |
0.4% 4k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||